GlobeNewswire (press release) ... the chemotherapy drug gemcitabine , to partially fund the clinical development of other clinical stage product candidates (including MM-398 for indications other than pancreatic cancer), to fund pre-clinical and research and development efforts and ... and more »
MedPage Today A 71-year-old woman with a history of multiple sclerosis developed SCLE after receiving a second dose of gemcitabine for a pulmonary metastasis from breast cancer. At diagnosis of SCLE, the woman had scaly erythematous patches on her arms and pink ...
OncLive Treatment with weekly nab-paclitaxel plus gemcitabine remains a strong independent predictor of both overall survival (OS) and progression-free survival (PFS) in patients with metastatic pancreatic cancer compared with gemcitabine alone, even after ...
RedOrbit Molecules in the milieu around the cancer cells, such as Connective Tissue Growth Factor (CTGF), provide “pro-life” signals that overcome the killing power of chemotherapeutic drugs . “In addition to drug delivery being a problem, there is also this ...
PMLiVE For late-stage patients, Brazil physicians are more likely to use an anthracycline-based regimen without a taxane in the first line, gemcitabine , paclitaxel or a combination of both in the second-line and other chemotherapeutics, such as vinorelbine ...
The Almagest They have shown that a combination of radiotherapy and the anti-cancer drug gemcitabine can increase survival following surgery for advanced pancreatic ca...
EurekAlert (press release) Tumors in mice treated with FG-3019 in combination with the chemotherapeutic drug gemcitabine stopped growing. Inside the tumor there was an increase in the amount of cancer cells dying through apoptosis, which was associated with a decrease in levels ... and more »
Yahoo! New Zealand News In preclinical studies, Rexahn's lead compound has shown anti-tumor activity against human cancer cell lines that do not respond well to paclitaxel, gemcitabine and cisplatin. “The granting of this patent further strengthens Rexahn's intellectual ... and more »
pharmabiz.com The European Medicines Agency's (the EMA) Committee for Medicinal Products for Human Use has accepted PIX306, CTI's ongoing randomized controlled phase III clinical trial, which compares Pixuvri-rituximab to gemcitabine -rituximab in patients who have ... and more »
Yahoo! News ... (FDA) has agreed to an End of Phase II meeting on August 20, 2013 to discuss TNIB's clinical development program and Chemistry and Manufacturing Control (CMC) plans for MENK[R] in combination with gemcitabine in the treatment of pancreatic cancer. and more »
